AZEDRA

Welcome to the Brand page for “AZEDRA”, which is offered here for Radiopharmaceutical compositions for treating neuro-endocrine cancers;.

Its status is currently believed to be active. Its class is unavailable. “AZEDRA” is believed to be currently owned by “MOLECULAR INSIGHT PHARMACEUTICALS, INC.”

Owner:
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Owner Details
Description:
Radiopharmaceutical compositions for treating neuro-endocrine cancers;
Categories: RADIOPHARMACEUTICAL COMPOSITIONS TREATING NEURO ENDOCRINE